Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-140.3%
operating margin TTM
-155.92%
revenue TTM
7.02 Billion
revenue per share TTM
17.98$
valuation ratios | |
|---|---|
| pe ratio | -4.29 |
| peg ratio | 0.60 |
| price to book ratio | 1.43 |
| price to sales ratio | 6.03 |
| enterprise value multiple | -4.70 |
| price fair value | 1.43 |
profitability ratios | |
|---|---|
| gross profit margin | 11.93% |
| operating profit margin | -155.92% |
| pretax profit margin | -141.96% |
| net profit margin | -140.3% |
| return on assets | -25.68% |
| return on equity | -31.4% |
| return on capital employed | -33.13% |
liquidity ratios | |
|---|---|
| current ratio | 3.93 |
| quick ratio | 3.73 |
| cash ratio | 0.67 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 61.95 |
| operating cycle | 291.04 |
| days of payables outstanding | 49.82 |
| cash conversion cycle | 241.22 |
| receivables turnover | 1.59 |
| payables turnover | 7.33 |
| inventory turnover | 5.89 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.06 |
| debt equity ratio | 0.08 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.07 |
| interest coverage | -432.88 |
| cash flow to debt ratio | -2.69 |
cash flow ratios | |
|---|---|
| free cash flow per share | -6.83 |
| cash per share | 11.55 |
| operating cash flow per share | -5.07 |
| free cash flow operating cash flow ratio | 1.35 |
| cash flow coverage ratios | -2.69 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | -2.89 |
Frequently Asked Questions
When was the last time Moderna, Inc. (NASDAQ:MRNA) reported earnings?
Moderna, Inc. (MRNA) published its most recent earnings results on 06-11-2025.
What is Moderna, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Moderna, Inc. (NASDAQ:MRNA)'s trailing twelve months ROE is -31.4%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Moderna, Inc. (MRNA) currently has a ROA of -25.68%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did MRNA's net profit margin stand at?
MRNA reported a profit margin of -140.3% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is MRNA's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 3.93 in the most recent quarter. The quick ratio stood at 3.73, with a Debt/Eq ratio of 0.08.